These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16232019)

  • 21. Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study.
    Tincani E; Mannucci C; Casolari B; Turrini F; Crowther MA; Prisco D; Cenci AM; Bondi M
    Haematologica; 2006 Jul; 91(7):976-9. PubMed ID: 16757417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.
    McKellar SH; Thompson JL; Garcia-Rinaldi RF; Macdonald RJ; Sundt TM; Schaff HV
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):908-14. PubMed ID: 18954629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of outcomes using 2 delivery models of anticoagulation care.
    Staresinic AG; Sorkness CA; Goodman BM; Pigarelli DW
    Arch Intern Med; 2006 May; 166(9):997-1002. PubMed ID: 16682573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
    Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin.
    Allou N; Piednoir P; Berroëta C; Provenchère S; Ibrahim H; Baron G; Montravers P; Iung B; Philip I; Ajzenberg N
    Heart; 2009 Oct; 95(20):1694-700. PubMed ID: 19482850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
    Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
    Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
    Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
    Spyropoulos AC; Turpie AG; Dunn AS; Kaatz S; Douketis J; Jacobson A; Petersen H;
    Am J Cardiol; 2008 Oct; 102(7):883-9. PubMed ID: 18805116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of warfarin therapy in the nursing home setting.
    Gurwitz JH; Field TS; Radford MJ; Harrold LR; Becker R; Reed G; DeBellis K; Moldoff J; Verzier N
    Am J Med; 2007 Jun; 120(6):539-44. PubMed ID: 17524757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
    Kovacs MJ; Wells PS; Anderson DR; Lazo-Langner A; Kearon C; Bates SM; Blostein M; Kahn SR; Schulman S; Sabri E; Solymoss S; Ramsay T; Yeo E; Rodger MA;
    BMJ; 2021 Jun; 373():n1205. PubMed ID: 34108229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.
    Rabbat CG; Cook DJ; Crowther MA; McDonald E; Clarke F; Meade MO; Lee KA; Cook RJ
    J Crit Care; 2005 Dec; 20(4):357-63. PubMed ID: 16310608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of guideline-based anticoagulation in a patient with mitral prosthetic valve and recurrent thromboembolism.
    Mutlu H; Yerlioglu ME; Levy WK
    J Am Soc Echocardiogr; 2008 Mar; 21(3):296.e1-3. PubMed ID: 17681732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis.
    Cook D; Sinuff T; Zytaruk N; Rabbat C; Lee A; O'Donnell M; Thabane L; Linkins L; Treleaven D; Patel R; Meade M; Crowther M; Marshall JC; Douketis J;
    J Crit Care; 2009 Jun; 24(2):168-75. PubMed ID: 19327956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve?
    Bayliss A; Faber P; Dunning J; Ronald A
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):390-6. PubMed ID: 17669876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.